MedPath

A clinical study to assess safety and efficacy of Velseal-T as haemostatic device after angioplasty/angiography compared to standard dressing.

Phase 4
Conditions
Health Condition 1: I998- Other disorder of circulatory system
Registration Number
CTRI/2019/05/019033
Lead Sponsor
Gp Capt Dr V Anand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other (Terminated)
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Males and females undergoing for angiography/ angioplasty.

2. Male and female of age between 18 to 85 years.

3. Subject who can provide informed consent form in written.

4. Subjects allowing their data to be collected for the study at predefined follow-ups.

Exclusion Criteria

1. Subject presented with medical emergency, where treatment is priority than the

informed consent process.

2. Subject or their LAR not able to provide informed consent in written.

3. Subject unwilling or unable to comply with the postoperative follow-ups necessary for

data collection.

4.Subjects with known hemorrhagic disorders like GI bleeding, Ante partum Haemorrhage,

Metropathia Haemorragica, History of Haematemesis, Haematuria, Epistaxis etc.

5.Subject with Genetic bleeding disorder.

6.Subjects with known possible loss of plasma or blood from other areas than wound such

as lacerations, Uterine bleeding, Gastro-intestinal bleeding etc.

7.The subject with an active infection at the site.

8.Subjects with evidence of bleeding or haematoma at the access site prior to sheath

removal.

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath